852237-32-2

Basic information

• Product Name: 2-Morpholinecarboxamide, N-methoxy-N-methyl-4-(phenylmethyl)-
• CAS NO: 852237-32-2
• Molecular Formula: C14H20N2O3
• Molecular Weight: 264.324
• Mol File: 852237-32-2.mol

Chemical Properties

• CAS DataBase Reference: 2-Morpholinecarboxamide, N-methoxy-N-methyl-4-(phenylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Morpholinecarboxamide, N-methoxy-N-methyl-4-(phenylmethyl)-(852237-32-2)
• EPA Substance Registry System: 2-Morpholinecarboxamide, N-methoxy-N-methyl-4-(phenylmethyl)-(852237-32-2)

Safety Data

• Hazardous Substances Data: 852237-32-2(Hazardous Substances Data)

Upstream product

• 5725-96-2 N,N-dimethylhydroxylamine 
• 75-24-1 trimethylaluminum 
• 135072-32-1 ethyl 4-benzylmorpholine-2-carboxylate 
• 769087-80-1 4-benzylmorpholine-2-carboxylic acid 
• 1117-97-1 N,0-dimethylhydroxylamine 
• 147767-51-9 4-benzyl-2-cyanomorpholine 
• 104-63-2 N-Benzylethanolamine 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 

Downstream Products

• 852237-49-1 (S)-4-benzyl-morpholine-2-carboxylic acid methoxy-methyl-amide 
• 852237-44-6 5,5,5-trifluoro-1-[4-(phenylmethyl)morpholin-2-yl]pentan-1-one 
• 852237-39-9 [4-(phenylmethyl)morpholin-2-yl](tetrahydro-2H-pyran-4-yl)methanone 
• 1305117-43-4 1-(4-benzylmorpholin-2-yl)ethanamine 
• 852237-37-7 3-methyl-1-[4-(phenylmethyl)morpholin-2-yl]butan-1-one 
• 852237-48-0 1-(4-benzyl-morpholin-2 yl)-pentan-1-one 
• 852237-34-4 1-(4-benzylmorpholin-2-yl)ethanone 

Relevant articles and documents

COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).

SUBSTITUTED TRIAZOLOPYRIMIDINES AS PDE8 INHIBITORS

Compounds of Formula (I): wherein R1 , R2, R3, R4, and R5 are as defined herein, are disclosed.

TREATMENT OF HOT FLASHES, IMPULSE CONTROL DISORDERS AND PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION

Selective norepinephrine reuptake inhibitors are useful for the prevention or treatment of hot flashes, vasomotor symptoms, impulse control disorders or personality change due to a general medical condition.

MORPHOLINE DERIVATIVES AS NOREPINEPHRINE REUPTAKE INHIBITORS

Compounds of the general formula (I) are inhibitors of the reuptake of norepinephrine. As such, they may be useful for the treatment of disorders of the central and/or peripheral nervous system.